Home › Calculator › OVID Dividend Calculator 2026
OVID Dividend DRIP Calculator 2026
71.81% YieldHealthcareOvid Therapeutics Inc. · NASDAQ
Price: $2.79 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When OVID pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your OVID snowball 📈
$10,000 in OVID → $40758928180.50M in 10 years · $3,391,964,740,073,412.50/month
About Ovid Therapeutics Inc. (OVID) — Dividend Analysis 2026
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV815, targeting neurological disorders connected to the kinesin-family of proteins. To bolster its research and development efforts, Ovid maintains licensing and collaborative agreements with prominent entities such as Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Marinus Pharmaceuticals, Inc. Established in 2014, the company's corporate headquarters are situated in New York, New York.
Compare OVID with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full OVID DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OVID position with:
🌍 OVID Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OVID.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 71.81% | 69.01% | $7,181 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 61.04% | 58.24% | $6,104 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 57.45% | 54.65% | $5,745 / yr |
| 🇬🇧 UK ISA | 0% | 71.81% | 69.01% | $7,181 / yr |
| 🇬🇧 UK Taxable | 8.75% | 65.53% | 62.73% | $6,553 / yr |
| 🇨🇦 TFSA | 0% | 71.81% | 69.01% | $7,181 / yr |
| 🇨🇦 CA Taxable | 25% | 53.86% | 51.06% | $5,386 / yr |
| 🇦🇺 Super (pension) | 15% | 61.04% | 58.24% | $6,104 / yr |
| 🇦🇺 AU Taxable | 30% | 50.27% | 47.47% | $5,027 / yr |
| 🇩🇪 DE Taxable | 26.375% | 52.87% | 50.07% | $5,287 / yr |
| 🇫🇷 FR Taxable | 30% | 50.27% | 47.47% | $5,027 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OVID Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OVID Dividend Payment Schedule
OVID pays quarterly — 4 times per year. Next ex-div: TBD.
📊 OVID vs Healthcare Benchmarks
How OVID compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OVID sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OVID Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-06 | 50,000 | — | — | ||
| Other | 2026-07-06 | 200,000 | $1.14 | $228.0K | ||
| Other | 2026-07-06 | 206,250 | $1.65 | $340.3K | ||
| A-Award | 2026-06-15 | 130,000 | $2.26 | $293.8K | ||
| A-Award | 2026-04-07 | 17,578 | $2.56 | $45.0K | ||
| A-Award | 2026-04-07 | 8,789 | $2.56 | $22.5K | ||
| A-Award | 2026-04-07 | 17,578 | $2.56 | $45.0K | ||
| M-Exempt | 2026-03-23 | 47,333 | $1.40 | $66.3K | ||
| M-Exempt | 2026-03-23 | 47,333 | $1.40 | $66.3K | ||
| A-Award | 2026-02-26 | 1,435,000 | $1.65 | $2.37M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OVID dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ovid Therapeutics Inc. (OVID) is currently trading at $2.79, 35% below its 52-week high. The current dividend yield is 71.81% based on an annual payout of $2.00 per share.
OVID (Ovid Therapeutics Inc.) — 71.81% Dividend Yield Analysis
Ovid Therapeutics Inc. (OVID) is a healthcare stock currently trading at $2.79 with a dividend yield of 71.81%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (71.81%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest OVID News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.